Preterm birth (PTB) continues to pose a challenge in neonatal medicine, and it is the major cause of perinatal morbidity and ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback